Total Payments
$1,559
2022 Payments
$126.76
Companies
14
Transactions
86
Medicare Patients
2,293
Medicare Billing
$345,368
Payment Breakdown by Category
Food & Beverage$1,559 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,559 | 86 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $444.39 | 26 | $0 (2022) |
| PFIZER INC. | $387.18 | 19 | $0 (2022) |
| UCB, Inc. | $235.29 | 12 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $159.06 | 9 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $96.56 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $72.39 | 4 | $0 (2021) |
| CSL Behring | $45.13 | 3 | $0 (2018) |
| Biohaven Pharmaceuticals, Inc. | $25.04 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.70 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $126.76 | 6 | PFIZER INC. ($67.09) |
| 2021 | $405.69 | 20 | PFIZER INC. ($152.70) |
| 2020 | $226.97 | 11 | PFIZER INC. ($91.49) |
| 2019 | $242.99 | 15 | UCB, Inc. ($77.14) |
| 2018 | $286.29 | 16 | UCB, Inc. ($91.41) |
| 2017 | $270.20 | 18 | Janssen Pharmaceuticals, Inc ($109.99) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/02/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Neurology | ||||||
| 02/12/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/14/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: WATCHMAN_IC | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/30/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: PRIMARY CARE | ||||||
| 09/30/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Cardiovascular | ||||||
| 09/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Neurology | ||||||
| 08/18/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/04/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.64 | General |
| Category: Cardiovascular | ||||||
| 07/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/07/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/23/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Cardiovascular | ||||||
| 06/09/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/28/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Cardiovascular | ||||||
| 04/14/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/02/2021 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $27.02 | General |
| 03/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 547 | 933 | $304,179 | $83,790 |
| 2022 | 8 | 567 | 1,081 | $267,991 | $87,934 |
| 2021 | 7 | 542 | 967 | $244,569 | $82,569 |
| 2020 | 8 | 637 | 1,066 | $265,882 | $91,076 |
Total Patients
2,293
Total Services
4,047
Medicare Billing
$345,368
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 205 | 547 | $157,536 | $47,658 | 30.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 129 | 135 | $75,195 | $16,978 | 22.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 163 | 167 | $49,432 | $14,076 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 52 | $10,400 | $3,036 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 32 | $11,616 | $2,041 | 17.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 198 | 674 | $150,976 | $50,491 | 33.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 105 | $45,675 | $14,494 | 31.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 128 | 128 | $29,568 | $9,961 | 33.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 34 | 35 | $14,000 | $4,506 | 32.2% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 34 | 46 | $10,396 | $3,091 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 37 | $8,584 | $2,505 | 29.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 27 | 28 | $4,396 | $1,444 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 28 | $4,396 | $1,443 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 179 | 569 | $127,456 | $43,181 | 33.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 85 | 87 | $37,845 | $12,912 | 34.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 120 | 123 | $28,413 | $9,808 | 34.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 61 | 61 | $24,400 | $7,808 | 32.0% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 43 | 64 | $14,464 | $4,884 | 33.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 28 | $6,496 | $2,108 | 32.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 35 | 35 | $5,495 | $1,866 | 34.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 198 | 565 | $126,560 | $43,937 | 34.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 101 | 104 | $45,240 | $15,480 | 34.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 139 | 141 | $32,571 | $11,493 | 35.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 58 | 58 | $23,200 | $7,349 | 31.7% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 40 | 65 | $14,690 | $5,061 | 34.5% |
About Dr. Pooja Deshmukh, M.D
Dr. Pooja Deshmukh, M.D is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700022704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pooja Deshmukh, M.D has received a total of $1,559 in payments from pharmaceutical and medical device companies, with $126.76 received in 2022. These payments were reported across 86 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,559).
As a Medicare-enrolled provider, Deshmukh has provided services to 2,293 Medicare beneficiaries, totaling 4,047 services with total Medicare billing of $345,368. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Omaha, NE
- Active Since 12/21/2008
- Last Updated 04/04/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700022704
Products in Payments
- ELIQUIS (Drug) $489.80
- XARELTO (Drug) $444.39
- Vimpat (Drug) $123.97
- Briviact (Drug) $111.32
- ENTRESTO (Drug) $72.39
- Kcentra (Biological) $45.13
- PNEUMOVAX 23 (Biological) $37.15
- CHANTIX (Drug) $29.42
- NURTEC ODT (Drug) $25.04
- XIFAXAN (Drug) $17.70
- STIOLTO RESPIMAT (Drug) $17.47
- Lexiscan (Drug) $17.11
- CUBICIN RF (Drug) $16.68
- WATCHMAN Access System (Device) $15.53
- ZERBAXA (Drug) $14.70
- ZIO Patch (Device) $14.57
- JANUVIA (Drug) $11.96
- CoreValve Evolut (Device) $11.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Internal Medicine $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Internal Medicine $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Internal Medicine $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Internal Medicine $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335
Internal Medicine $60,335